298 related articles for article (PubMed ID: 17045686)
1. The potential of oligonucleotides for therapeutic applications.
Fichou Y; Férec C
Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
[TBL] [Abstract][Full Text] [Related]
2. Targeting the human genome.
Tachikawa K; Briggs SP
Curr Opin Biotechnol; 2006 Dec; 17(6):659-65. PubMed ID: 17085035
[TBL] [Abstract][Full Text] [Related]
3. Latest development in viral vectors for gene therapy.
Lundstrom K
Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
[TBL] [Abstract][Full Text] [Related]
4. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
5. Production of plasmid DNA for pharmaceutical use.
Voss C
Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
[TBL] [Abstract][Full Text] [Related]
6. A new approach to gene therapy.
Zhang Z; Eriksson M; Blombäck M; Anvret M
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S39-42. PubMed ID: 9607112
[TBL] [Abstract][Full Text] [Related]
7. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells.
Kwaks TH; Otte AP
Trends Biotechnol; 2006 Mar; 24(3):137-42. PubMed ID: 16460822
[TBL] [Abstract][Full Text] [Related]
8. Gene targeting for gene therapy: prospects.
Lanzov VA
Mol Genet Metab; 1999 Oct; 68(2):276-82. PubMed ID: 10527679
[TBL] [Abstract][Full Text] [Related]
9. Does gene therapy become pharmacotherapy?
Morishita R; Aoki M; Ogihara T
Exp Physiol; 2005 May; 90(3):307-13. PubMed ID: 15778409
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy.
Liu CM; Liu DP; Liang CC
J Mol Med (Berl); 2002 Oct; 80(10):620-8. PubMed ID: 12395146
[TBL] [Abstract][Full Text] [Related]
12. Genetic therapies for cardiovascular diseases.
Melo LG; Pachori AS; Gnecchi M; Dzau VJ
Trends Mol Med; 2005 May; 11(5):240-50. PubMed ID: 15882612
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for cardiac arrhythmias: a dream soon to come true?
Donahue JK
J Cardiovasc Electrophysiol; 2007 May; 18(5):553-9. PubMed ID: 17456137
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
Kelly WJ
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy. The strange case of chimeraplasty.
Taubes G
Science; 2002 Dec; 298(5601):2116-20. PubMed ID: 12481116
[No Abstract] [Full Text] [Related]
16. RNA interference as an anticancer therapy: a patent perspective.
Dykxhoorn DM
Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927
[TBL] [Abstract][Full Text] [Related]
17. Positive clinical data in Parkinson's and ischemia buoy gene therapy.
Sheridan C
Nat Biotechnol; 2007 Aug; 25(8):823-4. PubMed ID: 17687344
[No Abstract] [Full Text] [Related]
18. Gene repair and transposon-mediated gene therapy.
Richardson PD; Augustin LB; Kren BT; Steer CJ
Stem Cells; 2002; 20(2):105-18. PubMed ID: 11897868
[TBL] [Abstract][Full Text] [Related]
19. Modification of hepatic genomic DNA using RNA/DNA oligonucleotides.
Kren BT; Chen Z; Felsheim R; Roy Chowdhury N; Roy Chowdhury J; Steer CJ
Gene Ther; 2002 Jun; 9(11):686-90. PubMed ID: 12032688
[TBL] [Abstract][Full Text] [Related]
20. Directed evolution for drug and nucleic acid delivery.
Hida K; Hanes J; Ostermeier M
Adv Drug Deliv Rev; 2007 Dec; 59(15):1562-78. PubMed ID: 17933418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
